Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.76 EUR | -0.40% | +2.50% | +50.31% |
29/04 | Abivax: share price rises as two analysts express optimism | CF |
29/04 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.31% | 993M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax : Stops Anti-Inflammatory Drug Study in High-Risk COVID-19 Patients Due to Ineffectiveness